Preinfarction angina: clinical significance and relationship with total ischemic time in patients with ST-elevation myocardial infarction

ObjectivesPreinfarction angina (PIA) may play a protective role in patients with ST-elevation myocardial infarction. Data on the relationship between PIA and time to reperfusion are scarce. We aimed to assess infarct size by peak troponin-T (TnT) in patients with or without PIA in three different time intervals to a primary percutaneous coronary intervention (PPCI), the relationship between PIA and left ventricular ejection fraction, and its impact on midterm survival. Patients and methodsSingle-center, retrospective analyses were carried out of 575 consecutive PPCI-treated patients, divided into three groups from symptom onset to reperfusion: less than 3, 3–6, and greater than 6 h. ResultsPatients with PIA had smaller infarct size [TnT=3.76 (5.07) vs. 5 (6.12) ng/ml, P=0.024]. Infarct size of patients with PIA versus no-PIA was lower for patients presenting within 3–6 h from onset of symptoms [3.73 (5.38) vs. 5.53 (6.9) ng/ml, P=0.028], but not different for those who presented less than 3 h [4.15 (5.53) vs. 4.0 (3.96) ng/ml, P=0.702] nor for those who presented greater than 6 h [3.65 (4.24) vs. 5.0 (5.9) ng/ml, P=0.141]. On multivariate analyses, only PIA protected from moderate to severe left ventricle dysfunction (odds ratio=0.557, 95% confidence interval: 0.352–0.881, P=0.012), but failed to reduce overall mortality [hazard ratio=0.784, 95% confidence interval: 0.356–1.724, P=0.545; median follow-up time=23 (20) months]. ConclusionPPCI-treated patients within 3–6 h from symptom onset had smaller infarcts if they had experienced PIA, with no benefit for those who presented less than 3 h nor for those who presented greater than 6 h from symptom onset. Moderate to severe left ventricle dysfunction was less prevalent in PIA patients. However, PIA failed to have an independent impact on midterm survival.

[1]  P. Armstrong,et al.  Clinical perspectives on reperfusion injury in acute myocardial infarction. , 2014, American heart journal.

[2]  M. Jeong,et al.  Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction. , 2013, International journal of cardiology.

[3]  E. Murphy,et al.  Did a Classic Preconditioning Study Provide a Clue to the Identity of the Mitochondrial Permeability Transition Pore? , 2013, Circulation research.

[4]  M. Ovize,et al.  Myocardial conditioning: opportunities for clinical translation. , 2013, Circulation research.

[5]  R. Kloner Current State of Clinical Translation of Cardioprotective Agents for Acute Myocardial Infarction , 2013, Circulation research.

[6]  Steven P Jones,et al.  Historical perspective on the pathology of myocardial ischemia/reperfusion injury. , 2013, Circulation research.

[7]  R. V. Vander Heide,et al.  Cardioprotection and Myocardial Reperfusion: Pitfalls to Clinical Application , 2013, Circulation research.

[8]  F. Crea,et al.  Effect of pre-infarction angina on platelet reactivity in acute myocardial infarction. , 2013, International journal of cardiology.

[9]  A. Giovagnoni,et al.  Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. , 2012, International journal of cardiology.

[10]  Jean-Claude Tardif,et al.  Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry , 2012, European heart journal.

[11]  D. Hausenloy Conditioning the heart to prevent myocardial reperfusion injury during PPCI , 2012, European heart journal. Acute cardiovascular care.

[12]  T. Ahmed,et al.  Pre-infarction angina predicts thrombus burden in patients admitted for ST-segment elevation myocardial infarction. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[13]  R. Kloner,et al.  An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. , 2012, Journal of the American College of Cardiology.

[14]  M. Schocke,et al.  Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI , 2011, Clinical Research in Cardiology.

[15]  K. Eagle,et al.  Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective. , 2010, European heart journal.

[16]  C. Terkelsen,et al.  Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial , 2010, The Lancet.

[17]  C. Catalano,et al.  Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. , 2009, Journal of the American College of Cardiology.

[18]  B. Gersh,et al.  Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The “Dark Side” of Reperfusion , 2009, Circulation.

[19]  J. Monassier Reperfusion injury in acute myocardial infarction. From bench to cath lab. Part I: Basic considerations. , 2008, Archives of cardiovascular diseases.

[20]  A. Jaffe,et al.  Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. , 2008, Journal of the American College of Cardiology.

[21]  O. Morel,et al.  Role of pre-infarction angina and inflammatory status in the extent of microvascular obstruction detected by MRI in myocardial infarction patients treated by PCI. , 2007, International journal of cardiology.

[22]  Daniel C. Lee,et al.  Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging. , 2007, European heart journal.

[23]  J. McMurray,et al.  Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. , 2006, The American journal of cardiology.

[24]  P. Serruys,et al.  The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[25]  M. Galvani,et al.  Prodromal angina limits infarct size in the setting of acute anterior myocardial infarction treated with primary percutaneous intervention. , 2005, Journal of the American College of Cardiology.

[26]  B. Gersh,et al.  Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? , 2005, JAMA.

[27]  R. Giugliano,et al.  Usefulness of prodromal unstable angina pectoris in predicting better survival and smaller infarct size in acute myocardial infarction (The InTIME-II Prodromal Symptoms Substudy). , 2003, The American journal of cardiology.

[28]  R. Guyton,et al.  Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. , 2003, American journal of physiology. Heart and circulatory physiology.

[29]  D. Liem,et al.  Transient limb ischemia induces remote ischemic preconditioning in vivo. , 2003, Circulation.

[30]  K. Nishioka,et al.  Effect of prodromal angina pectoris on altering the relation between time to reperfusion and outcomes after a first anterior wall acute myocardial infarction. , 2003, The American journal of cardiology.

[31]  P. Colonna,et al.  Reduced microvascular and myocardial damage in patients with acute myocardial infarction and preinfarction angina. , 2002, American heart journal.

[32]  M. Rodríguez,et al.  Effect of preexisting angina pectoris on left ventricular function following acute myocardial infarction treated with thrombolysis or coronary angioplasty. , 2002, The American journal of cardiology.

[33]  G. Heusch Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug? , 2001, Circulation.

[34]  R. Bolli,et al.  Delayed Preconditioning-Mimetic Action of Nitroglycerin in Patients Undergoing Coronary Angioplasty , 2001, Circulation.

[35]  M. A. Rodríguez,et al.  Pre-infarction angina elicits greater myocardial viability on reperfusion after myocardial infarction: a dobutamine stress echocardiographic study. , 2001, Journal of the American College of Cardiology.

[36]  Grace Investigators,et al.  Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. , 2001, American heart journal.

[37]  E. Antman,et al.  TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy , 2000, Circulation.

[38]  Eric Boersma,et al.  Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour , 1996, The Lancet.

[39]  A. Maseri,et al.  Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. , 1996, The New England journal of medicine.

[40]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[41]  W. Hort,et al.  Quantitative study on the size of coronary artery supplying areas postmortem. , 1977, American heart journal.

[42]  G. De Luca,et al.  Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty. , 2013, Atherosclerosis.

[43]  J. Alpert,et al.  The third universal definition of myocardial infarction , 2013 .

[44]  K. Mahaffey,et al.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation , 2012 .

[45]  M. Masotti,et al.  Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. , 2012, European heart journal.

[46]  P. Serruys,et al.  Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Me , 2011, JACC. Cardiovascular interventions.

[47]  L. Becker Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.

[48]  G. Schuler,et al.  Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry. , 2001, The American journal of cardiology.

[49]  C. Cannon,et al.  Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? , 1995, Circulation.

[50]  P. Brandt,et al.  Coronary arteriography; method of presentation of the arteriogram report and a scoring system. , 1977, Clinical radiology.